Birdwatch Note
2024-12-13 06:47:19 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Medications like semaglutide are GLP-1 receptor agonists, not inhibitors. While Heying's concerns are not irrational, existing data (including those from pharma sponsored trials), were reviewed in this non-pharma sponsored study which found cardiac benefits to GLP-1R agonists. https://pubmed.ncbi.nlm.nih.gov/39568487/
Written by 1C3A7E8F8E4860C08C6C5088AD747DD852D730FFF0D7830C8D2BA3C47DF35C87
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1866934266397069583
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1867461279671083292
- noteId - 1867461279671083292
- participantId -
- noteAuthorParticipantId - 1C3A7E8F8E4860C08C6C5088AD747DD852D730FFF0D7830C8D2BA3C47DF35C87 Participant Details
- createdAtMillis - 1734072439484
- tweetId - 1866934266397069583
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Medications like semaglutide are GLP-1 receptor agonists, not inhibitors. While Heying's concerns are not irrational, existing data (including those from pharma sponsored trials), were reviewed in this non-pharma sponsored study which found cardiac benefits to GLP-1R agonists. https://pubmed.ncbi.nlm.nih.gov/39568487/